Cancer Detection and Liquid Biopsy
Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.
Read MorePosted by Steve Halasey | Apr 13, 2020 | Cancer, Molecular Diagnostics, Pancreatic, Specimen Collection & Handling |
Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.
Read MorePosted by | Apr 8, 2020 | Lung Cancer, Urinalysis & Toxicology |
A noninvasive urine test that can detect the presence of proteins linked to lung cancer could help detect more tumors in the early stages of the disease.
Read MorePosted by | Apr 6, 2020 | Molecular Diagnostics |
The agreement will help both companies pursue FDA approval for their diagnostic testing services and specimen collection products.
Read MorePosted by | Apr 6, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types |
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read MorePosted by | Mar 31, 2020 | Computing Systems, Information Technology, Middleware & Software |
Qlucore is expanding its bioinformatics software business into precision medicine and precision diagnostics.
Read More